Research Topics
| Rachel J GorwitzSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
|
Detail Information
Publications
Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004Rachel J Gorwitz
National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Infect Dis 197:1226-34. 2008..Staphylococcus aureus is a common cause of infection, particularly in persons colonized by this organism. Virulent strains of methicillin-resistant S. aureus (MRSA) have emerged in the general community...
A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infectionsRachel J Gorwitz
Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pediatr Infect Dis J 27:1-7. 2008..Educating patients on strategies to prevent further transmission is a critical component of case management. More data are needed to determine optimal strategies for management and prevention of MRSA skin infections in the community...
Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004Fernanda C Lessa
Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 28:577-81. 2009..We assessed the scope and magnitude of MRSA infections with disease onset after 3 days of age (late-onset MRSA infections) in NICUs...
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and updateRachel J Gorwitz
Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 27:925-6. 2008
Methicillin-resistant Staphylococcus aureus: a primer for dentistsR Monina Klevens
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Am Dent Assoc 139:1328-37. 2008....
Mupirocin resistanceJean B Patel
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Clin Infect Dis 49:935-41. 2009..Institutions that are considering the implementation of widespread mupirocin use should consider these resistance issues and develop strategies to monitor the impact of mupirocin use...
Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the communityRachel J Gorwitz
J Infect Dis 197:179-82. 2008
The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureusRachel J Gorwitz
Clin Infect Dis 44:785-7. 2007
High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health centerLinda L Han
State Laboratory Institute, 305 South St, Jamaica Plain, MA 02130, USA
J Clin Microbiol 45:1350-2. 2007..The clindamycin, tetracycline, and mupirocin resistance genes identified in these isolates are commonly associated with plasmids...
Methicillin-resistant S. aureus infections among patients in the emergency departmentGregory J Moran
Department of Emergency Medicine, Olive View UCLA Medical Center, Sylmar, Calif 91342, USA
N Engl J Med 355:666-74. 2006..Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the community without established risk factors for MRSA...
